Found 5 matching trials
Safety and Tolerability Study of Recombinant L-IFN Adenovirus Injection in Patients With Recurrent Glioblastoma
EARLY_PHASE1The target subjects were patients with histologically or cytologically conf...
Location
Binhai Hospital of Fujian Medical University
Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical Study
EARLY_PHASE1This is an open-label, dose escalation study of the safety and tolerability...
Location
Shanghai Fengxian District Central Hospital
Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)
PHASE1The goal of this Phase I/II observational and interventional platform study...
Location
Multiple Locations
YSCH-01 Via Nebulization in Pulmonary Metastasis of Advanced Solid Tumors and Non-small Cell Lung Cancer (NSCLC)
EARLY_PHASE1This is an open-label, dose-escalation and cohort expansion study to evalua...
Location
No.17 Panjiayuan Nanli, Chaoyang District, Beijing
Evaluating Safety, Tolerability, and Preliminary Efficacy of YSCH-01 Monotherapy and in Combination With Atezolizumab for Recurrent Glioblastoma
EARLY_PHASE1The clinical study of YSCH-01 will adopt an open-label, randomized design, ...